Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Investments
Canadian dairy health technology specialist SomaDetect has completed its most recent seed funding round, raising $2 million.
Boulder, Colorado-based PanTheryx is focused on addressing gastrointestinal microbiome-related health conditions in humans and animals. Animal Pharm editor Joseph Harvey spoke to the company's executive vice president George Stagnitti about how it is bringing a science-backed approach to the animal nutrition sector.
Evonik Industries' venture capital arm has invested in a US fund, in order to access new technologies.
Polish bacteriophage specialist Proteon Pharmaceuticals has secured a €2.9 million ($3.2 million) grant from the European Regional Development Fund.
US feed additive start-up Agrivida has followed a recent US FDA approval with the closing of the first stage of a $20 million investment round.
US company PetCure Oncology has enlisted an investment banking firm to help it pursue an initial public offering (IPO).
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.